Peptide Encyclopedia / Prostamax
EncyclopediaProstamax is a synthetic prostate-targeted peptide from the Khavinson bioregulator family, related to Libidon and built around the tetrapeptide Lys-Glu-Asp-Pro. Its proposed action rests on limited Russian preclinical and small clinical reports, and it stays a US gray-market research chemical. Educational only, not medical advice.
| Category | Sexual Health |
| Regulatory status | Not FDA-approved; research chemical / gray-market in the US. |
A short synthetic prostate-targeted peptide preparation from the Khavinson bioregulator family (related to/marketed alongside the prostate bioregulator commonly called Libidon; a frequently cited core sequence is the tetrapeptide Lys-Glu-Asp-Pro). Proposed (unproven) mechanism is tissue-specific modulation of gene expression supporting prostate function. Mechanism is proposed, not established. (Naming/branding overlaps with peptide-bioregulator 'complexes', so composition varies by source.)
uncertain / limited human pharmacokinetic data; presumed rapid clearance but no rigorous human PK exists.
Not FDA-approved; research chemical / gray-market in the US. Not an FDA-approved drug; related prostate bioregulator preparations are sold within Russia in the supplement/bioregulator context only.
Human safety data are minimal and largely Russian-sourced. Rapid clearance suggests low acute risk but is not a substitute for controlled safety data. Branding/composition ambiguity and gray-market purity are concerns.
Weak/limited evidence base: predominantly Russian preclinical and small clinical reports tied to the Khavinson program, with little independent Western replication.
PepWise is an informational and educational tracking tool, not medical advice and not a medical device. Prostamax may be experimental, restricted, or prescription-only; many research peptides are not FDA-approved. Consult a licensed healthcare provider before starting, changing, or stopping any protocol. Operated by STC Consulting, Inc.
